Arcellx beat EPS estimates by $0.02 with $-1.01 vs expected $-1.03
Revenue fell significantly short at $1.65M vs $12.52M estimate
Stock price has risen 75.55% over the past year despite revenue shortfall
Company has received positive EPS revisions recently
📖 Full Retelling
Arcellx (NASDAQ: ACLX) reported first quarter earnings results on February 28, 2026, revealing that the biotechnology company beat earnings per share estimates by $0.02 despite falling short on revenue projections, as investors assessed the company's financial performance amid its recent stock gains. The Maryland-based biotech firm posted an EPS of $-1.01 for the quarter, which was $0.02 better than the analyst consensus estimate of $-1.03. However, the company's revenue of $1.65 million significantly lagged behind the $12.52 million expected by analysts, indicating potential challenges in the company's revenue generation strategies. Despite this revenue shortfall, Arcellx's stock price closed at $113.79, reflecting investor confidence that may be attributed to other factors beyond just quarterly revenue figures. The company has demonstrated strong stock performance recently, with shares climbing 65.37% over the past three months and 75.55% over the last twelve months. Market analysts have noted positive sentiment toward Arcellx, evidenced by one positive EPS revision and no negative revisions in the last 90 days.
🏷️ Themes
Earnings Results, Stock Performance, Financial Health
Total amount of income generated by the sale of goods or services
In accounting, revenue is the total amount of income generated by the sale of goods and services related to the primary operations of a business.
Commercial revenue may also be referred to as sales or as turnover. Some companies receive revenue from interest, royalties, or other fees.
Earnings are the net benefits of a corporation's operation. Earnings are also the amount on which corporate tax is due. For an analysis of specific aspects of corporate operations several more specific terms are used as EBIT (earnings before interest and taxes) and EBITDA (earnings before interest,...
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry U.S., Israel strike Iran; Trump says Khamenei killed U.S., Israel strike Iran — what is known so far Strategists see only temporary market impact from Iran strikes Bitcoin prices fall below $64,000 after U.S./Israel attack on Iran (South Africa Philippines Nigeria) Arcellx earnings beat by $0.02, revenue fell short of estimates By Investing.com Earnings Published 02/28/2026, 11:18 PM Arcellx earnings beat by $0.02, revenue fell short of estimates 0 ACLX -0.08% Investing.com - Arcellx (NASDAQ: ACLX ) reported first quarter EPS of $-1.01, $0.02 better than the analyst estimate of $-1.03. Revenue for the quarter came in at $1.65M versus the consensus estimate of $12.52M. Arcellx’s stock price closed at $113.79. It is up 65.37% in the last 3 months and up 75.55% in the last 12 months. Arcellx saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Arcellx’s stock price’s past reactions to earnings here . According to InvestingPro , Arcellx’s Financial Health score is " fair performance ". Check out Arcellx’s recent earnings performance , and Arcellx’s financials here . Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
